Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes—cardiovascular and renal benefits in patients with chronic kidney disease

被引：0
|
作者：
Tamara Y. Milder
Sophie L. Stocker
Dorit Samocha-Bonet
Richard O. Day
Jerry R. Greenfield
机构：
[1] St. Vincent’s Hospital,Department of Diabetes and Endocrinology
[2] St. Vincent’s Hospital,Department of Clinical Pharmacology and Toxicology
[3] University of NSW,St. Vincent’s Clinical School
[4] Garvan Institute of Medical Research,Diabetes and Metabolism
来源：
European Journal of Clinical Pharmacology | 2019年 / 75卷
关键词：
SGLT2 inhibitor; Pharmacokinetics; Cardiovascular outcomes; Efficacy; Safety; Chronic kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1481 / 1490
页数：9
相关论文
共 50 条
  • [1] Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes-cardiovascular and renal benefits in patients with chronic kidney disease
    Milder, Tamara Y.
    Stocker, Sophie L.
    Samocha-Bonet, Dorit
    Day, Richard O.
    Greenfield, Jerry R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (11) : 1481 - 1490
  • [2] Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes
    Lam, Steven Ho Man
    Alam, Uazman
    Lip, Gregory Yoke Hong
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 223 : 183 - 185
  • [3] Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement
    Roy, Ajitesh
    Maiti, Animesh
    Sinha, Anirban
    Baidya, Arjun
    Basu, Asish Kumar
    Sarkar, Dasarathi
    Sanyal, Debmalya
    Biswas, Dibakar
    Maisnam, Indira
    Pandit, Kaushik
    Raychaudhuri, Moutusi
    Sengupta, Nilanjan
    Chakraborty, Partha Pratim
    Mukhopadhyay, Pradip
    Raychaudhuri, Pradip
    Sahana, Pranab Kumar
    Chatterjee, Purushottam
    Bhattacharjee, Rana
    Dasgupta, Ranen
    Saraogi, Ravi Kant
    Pal, Salil Kumar
    Mukhopadhyay, Sarmishtha
    Mukhopadhyay, Satinath
    Goswami, Soumik
    Chowdhury, Subhankar
    Ghosh, Sujoy
    DIABETES THERAPY, 2020, 11 (12) : 2791 - 2827
  • [4] Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease
    Lin, Donna S. -H.
    Lee, Jen-Kuang
    Huang, Kuan-Chih
    Lin, Ting-Tse
    Lo, Hao-Yun
    DIABETOLOGIA, 2024, 67 (11) : 2459 - 2470
  • [5] Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement
    Ajitesh Roy
    Animesh Maiti
    Anirban Sinha
    Arjun Baidya
    Asish Kumar Basu
    Dasarathi Sarkar
    Debmalya Sanyal
    Dibakar Biswas
    Indira Maisnam
    Kaushik Pandit
    Moutusi Raychaudhuri
    Nilanjan Sengupta
    Partha Pratim Chakraborty
    Pradip Mukhopadhyay
    Pradip Raychaudhuri
    Pranab Kumar Sahana
    Purushottam Chatterjee
    Rana Bhattacharjee
    Ranen Dasgupta
    Ravi Kant Saraogi
    Salil Kumar Pal
    Sarmishtha Mukhopadhyay
    Satinath Mukhopadhyay
    Soumik Goswami
    Subhankar Chowdhury
    Sujoy Ghosh
    Diabetes Therapy, 2020, 11 : 2791 - 2827
  • [6] Renal Glucose Handling Impact of chronic kidney disease and sodium-glucose cotransporter 2 inhibition in patients with type 2 diabetes
    Ferrannini, Ele
    Veltkamp, Stephan A.
    Smulders, Ronald A.
    Kadokura, Takeshi
    DIABETES CARE, 2013, 36 (05) : 1260 - 1265
  • [7] The renal effects of sodium-glucose cotransporter type 2 inhibitors in patients with cardiovascular disease with and without chronic renal failure
    Benvenuto, Manuela
    Panzarella, Gaetano
    Shehaj, Ermal
    Valenti, Chiara
    Caldarola, Pasquale
    Colivicchi, Furio
    Gabrielli, Domenico
    Iacoviello, Massimo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2023, 24 (03) : 188 - 195
  • [8] Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review
    Sarker, Aditi
    Ramesh, Adarsh Srinivas
    Munoz, Carlos
    Jamil, Dawood
    Tran, Hadrian Hoang-Vu
    Mansoor, Mafaz
    Butt, Samia Rauf
    Satnarine, Travis
    Ratna, Pranuthi
    Hamid, Pousette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [9] Impact of sodium-glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria
    Nakamura, Akinobu
    Miyoshi, Hideaki
    Kameda, Hiraku
    Yamashita, Kumiko
    Kurihara, Yoshio
    DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01):
  • [10] Use of Sodium-glucose Cotransporter 2 Inhibitors in Patients with Chronic Kidney Disease
    Alkhunaizi, Ahmed M.
    Khairalla, Hanan
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2023, 34 (05) : 468 - 473
12345